Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?

Authors: J E Compston; L W Horton; M F Laker; A B Ayers; J S Woodhead; H J Bull; J C Gazet; T R Pilkington
Journal: Lancet Date: 1978-07-01 Impact factor: 79.321

6. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

Authors: W P Castelli; J T Doyle; T Gordon; C G Hames; M C Hjortland; S B Hulley; A Kagan; W J Zukel
Journal: Circulation Date: 1977-05 Impact factor: 29.690

7. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors: T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal: Am J Med Date: 1977-05 Impact factor: 4.965

8. Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.

Authors: J M Cruickshank; K Pennert; A E Sörman; J M Thorp; F M Zacharias; F J Zacharias
Journal: J Hypertens Date: 1987-08 Impact factor: 4.844

Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?

1. High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.

2. Beta-blockers and plasma triglycerides.

3. The effects of propranolol on cholesterol-induced atheromatous lesions.

4. Optimised blood-pressure.

5. Bone disease after jejuno-ileal bypass for obesity.

6. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

7. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

8. Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.

9. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

10. Coronary heart-disease after treatment of hypertension.

Review 1. The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Review 2. Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

3. Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension.